Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2008 045 365.0 |
96 | EP file number | EAKZ | 08 86 4495.0 |
86 | WO file number | WAKZ | PCT/CA2008/002277 |
97 | EP publication number | EPN | 2222710 |
87 | WO publication number | WPN | 2009079796 |
54 | Designation/title | TI | REKOMBINANTE RSV-ANTIGENE |
51 | IPC main class | ICM (ICMV) | C07K 19/00 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 39/00 (2006.01), A61K 39/155 (2006.01), A61K 39/295 (2006.01), A61K 9/107 (2006.01), A61P 31/14 (2006.01), A61P 37/04 (2006.01), C07K 14/135 (2006.01), C12N 15/45 (2006.01), C12N 15/62 (2006.01), C07K 14/005 (2006.01), A61K 9/127 (2025.01) |
22 | DE application date | DAT | Dec 23, 2008 |
96 | EP application date | EAT | Dec 23, 2008 |
86 | WO application date | WAT | Dec 23, 2008 |
43 | Date of first publication | OT | Jul 2, 2009 |
| Date of publication of grant | PET | Jul 27, 2016 |
71/73 | Applicant/owner | INH | GlaxoSmithKline Biologicals S.A., Rixensart, Brussels, BE |
72 | Inventor | IN | BAUDOUX, Jean-Pierre, B-1330 Rixensart, BE; BLAIS, Normand, LavalQuébec H6V 3S8, CA; RHEAULT, Patrick, LavalQuébec H7V 3S8, CA; RUELLE, Jean-Louis, B-1330 Rixensart, BE |
74 | Representative | VTR | VOSSIUS & PARTNER Patentanwälte Rechtsanwälte mbB, 81675 München, DE |
| Address for service | | VOSSIUS & PARTNER Patentanwälte Rechtsanwälte mbB, 81634 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 16524 P Dec 24, 2007
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 56206 P May 27, 2008
|
| Due date | FT FG | Dec 31, 2025 Annual fee for the 18th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR |
81 | Designated WO countries | WDS | AL, RS, BA, MK |
| Published EP/WO documents | EPWOPN | Original document:
EP000002222710 Searchable text:
EP000002222710 Original document:
EP000002222710B1 Searchable text:
EP000002222710B1 Original document:
WO002009079796 Searchable text:
WO002009079796 |
43 | Date of first publication | EVT | Jul 2, 2009 |
| Date of the first transfer into DPMAregister | EREGT | May 26, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Nov 30, 2024 (Show all update days)(Hide all update days)- Nov 30, 2024
- IPC secondary class(es): changed
- Due date: changed
- Jun 8, 2024; Mar 7, 2024; Jan 30, 2024; Nov 29, 2023; Jun 30, 2022; Nov 24, 2021; Nov 17, 2020; Nov 21, 2019; Nov 22, 2018; Oct 25, 2018; Jan 17, 2018; Aug 10, 2017; Jul 6, 2017; Jan 12, 2017; Nov 15, 2016; Aug 18, 2016; Aug 3, 2016; Jul 28, 2016; May 29, 2015; Feb 15, 2013
- Historical data not available for this/these date(s)
- May 26, 2011
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 11)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jan 29, 2024 |
| Issue number | HN | 10 |
| Year | PJ | 2024 |
| Publication date | VT | Mar 7, 2024 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | GlaxoSmithKline Biologicals S.A., Rixensart, Brussels, BE |
71/73 | Previous applicant/owner | INHF | GlaxoSmithKline Biologicals S.A., Rixensart, Brussels, BE, ID Biomedical Corporation of Quebec, Ste Foy, Quebec, CA |
| Date of update of the procedure | REGT | Mar 7, 2024 |